GSS and MAP agree to Commercial Terms for Merger
Filed with ASX · · 6 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- 2026 Annual Report & Appendix 4E
- 2026 Appendix 4G
- 2026 Corporate Governance Statement
- Genetic Signatures and Microba in Merger Discussions
- Change of Director's Interest Notice - Pasquale Rombola
Later from Microba Life Sciences
- Appointment of Interim Chief Executive Officer
- Change in substantial holding
- Microba launches GI Navigator in Australia and the UK
- Notification of cessation of securities - MAP
- Date of AGM and closing date for Director Nominations
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences